Literature DB >> 33825118

Fresh embryo transfer versus freeze-only after in vitro maturation with a pre-maturation step in women with high antral follicle count: a randomized controlled pilot study.

Lan N Vuong1,2, Linh K Nguyen3, Anh H Le3, Huy H Pham3, Vu Na Ho3, Ho L Le3, Toan D Pham3, Vinh Q Dang3, Tuan H Phung3, Johan Smitz4, Tuong M Ho3.   

Abstract

PURPOSE: In vitro maturation (IVM) is an alternative to in vitro fertilization (IVF) for women at high risk of developing ovarian hyperstimulation syndrome (OHSS). This study determined the effectiveness and safety of a freeze-only strategy versus fresh embryo transfer (ET) after IVM with a pre-maturation step (CAPA-IVM) in women with a high antral follicle count (AFC).
METHODS: This randomized, controlled pilot study (NCT04297553) was conducted between March and November 2020. Forty women aged 18-37 years with a high AFC (≥24 follicles in both ovaries) undergoing one cycle of CAPA-IVM were randomized to a freeze-only strategy with subsequent frozen ET (n = 20) or to fresh ET (n = 20). The primary endpoint was ongoing pregnancy resulting in live birth after the first ET of the started treatment cycle.
RESULTS: The ongoing pregnancy rate in the freeze-only group (65%) was significantly higher than that in the fresh ET group (25%; p = 0.03), as was the live birth rate (60% versus 20%; p = 0.02). Clinical pregnancy rate was numerically, but not significantly, higher after frozen versus fresh ET (70% versus 35%; p = 0.06), while the number of day 3 or good quality embryos, endometrial thickness on the day of oocyte pick-up, implantation rate, and positive pregnancy test rate did not differ significantly between groups. No cases of OHSS were observed, and miscarriage and multiple pregnancy rates were similar in the two groups.
CONCLUSIONS: These findings suggest that the effectiveness of CAPA-IVM could be improved considerably by using a freeze-only strategy followed by frozen ET in subsequent cycles. TRIAL REGISTRATION NUMBER: NCT04297553 ( www.clinicaltrials.gov ).

Entities:  

Keywords:  Fresh embryo transfer; Frozen embryo transfer; In vitro maturation; Infertility; Live birth; Ongoing pregnancy; Polycystic ovary syndrome

Mesh:

Year:  2021        PMID: 33825118      PMCID: PMC8266980          DOI: 10.1007/s10815-021-02180-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  32 in total

1.  Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting.

Authors: 
Journal:  Reprod Biomed Online       Date:  2011-04-11       Impact factor: 3.828

Review 2.  In vitro maturation: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2020-12-24       Impact factor: 7.329

3.  The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count.

Authors:  Vu N A Ho; Sanne C Braam; Toan D Pham; Ben W Mol; Lan N Vuong
Journal:  Hum Reprod       Date:  2019-06-04       Impact factor: 6.918

4.  Transfer of Fresh versus Frozen Embryos in Ovulatory Women.

Authors:  Yuhua Shi; Yun Sun; Cuifang Hao; Heping Zhang; Daimin Wei; Yunshan Zhang; Yimin Zhu; Xiaohui Deng; Xiujuan Qi; Hong Li; Xiang Ma; Haiqin Ren; Yaqin Wang; Dan Zhang; Bo Wang; Fenghua Liu; Qiongfang Wu; Ze Wang; Haiyan Bai; Yuan Li; Yi Zhou; Mei Sun; Hong Liu; Jing Li; Lin Zhang; Xiaoli Chen; Songying Zhang; Xiaoxi Sun; Richard S Legro; Zi-Jiang Chen
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

5.  In-vitro fertilization and the ovarian hyperstimulation syndrome.

Authors:  M J MacDougall; S L Tan; H S Jacobs
Journal:  Hum Reprod       Date:  1992-05       Impact factor: 6.918

6.  Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study.

Authors:  Evangelos G Papanikolaou; Elke D'haeseleer; Greta Verheyen; Hilde Van de Velde; Michael Camus; Andre Van Steirteghem; Paul Devroey; Herman Tournaye
Journal:  Hum Reprod       Date:  2005-07-29       Impact factor: 6.918

7.  Day 5 versus day 3 embryo transfer: a controlled randomized trial.

Authors:  S Coskun; J Hollanders; S Al-Hassan; H Al-Sufyan; H Al-Mayman; K Jaroudi
Journal:  Hum Reprod       Date:  2000-09       Impact factor: 6.918

Review 8.  Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.

Authors:  P Humaidan; S M Nelson; P Devroey; C C Coddington; L B Schwartz; K Gordon; J L Frattarelli; B C Tarlatzis; H M Fatemi; P Lutjen; B J Stegmann
Journal:  Hum Reprod       Date:  2016-06-23       Impact factor: 6.918

9.  Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome.

Authors:  V N A Ho; T D Pham; A H Le; T M Ho; L N Vuong
Journal:  J Ovarian Res       Date:  2018-08-27       Impact factor: 4.234

View more
  2 in total

1.  Natural cycles achieve better pregnancy outcomes than artificial cycles in non-PCOS women undergoing vitrified single-blastocyst transfer: a retrospective cohort study of 6840 cycles.

Authors:  Jing Li; Qian Sun; Meng Zhang; Xiao Fu; Yiting Zhang; Shanshan Gao; Jinlong Ma
Journal:  J Assist Reprod Genet       Date:  2022-02-04       Impact factor: 3.412

Review 2.  Perspectives on the development and future of oocyte IVM in clinical practice.

Authors:  Michel De Vos; Michaël Grynberg; Tuong M Ho; Ye Yuan; David F Albertini; Robert B Gilchrist
Journal:  J Assist Reprod Genet       Date:  2021-07-03       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.